Kim MacMartin-Moglia currently serves as Vice President of Business Development at InterVenn Biosciences since January 2022, having previously held the role of Senior Director of Pharma Business Development. Prior to this, Kim was the Director of Business Development at Werfen Autoimmunity from July 2013 to January 2022, focusing on in-licensing intellectual property for autoimmune biomarkers, developing collaborative research agreements, and managing the IP portfolio. Earlier career experience includes positions as Director of Business Development at Prometheus and Corporate Marketing Manager at Quest Diagnostics. Kim holds a B.A. in Biochemistry and Cell Biology from UC San Diego and an M.B.A. in Marketing and Finance from the University of San Diego.
Sign up to view 0 direct reports
Get started